Send to

Choose Destination
See comment in PubMed Commons below
Arch Physiol Biochem. 2010 Oct-Dec;116(4-5):174-80. doi: 10.3109/13813455.2010.501082. Epub 2010 Jul 22.

ProteoMiner™ and SELDI-TOF-MS: a robust and highly reproducible combination for biomarker discovery from whole blood serum.

Author information

Department of Clinical Biochemistry and Pathobiochemistry, Heinrich-Heine-University, Leibniz Centre for Diabetes Research, Düsseldorf, Germany.


Surface-enhanced laser desorption ionization time of flight mass spectrometry (SELDI-TOF-MS) has been recognized as an appropriate technology for biomarker discovery. Nevertheless, whenever human blood serum is studied, its sensitivity is restricted due to the wide dynamic range of serum protein concentrations. In this context, sample pre-fractionation targeting the low abundant proteins may help to overcome these limitations. Here, we evaluate the combination of ProteoMiner™ pre-fractionation and SELDI based protein profiling. We introduce a simplified workflow and demonstrate the high sensitivity and reproducibility of this combined profiling approach. Our analyses show that this combination is suitable for large-scale serum proteome profiling studies yielding reliable and reproducible results.

[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Taylor & Francis
    Loading ...
    Support Center